SCHEMBL8554945

SCHEMBL8554945

CC(=N)C(C(=O)OCc1ccccc1)C(C)C

nearest known ligand 0.56

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.56
CTSB P07858 2/20 0.54
TDP1 Q9NUW8 2/20 0.46
MAPK1 P28482 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
KMT2A Q03164 1/20 0.46
ELANE P08246 2/20 0.44
SLC15A1 P46059 1/20 0.44
ATM Q13315 1/20 0.43
LMNA P02545 1/20 0.42
HCAR2 Q8TDS4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24713353 0.89 ALDH1A1 (0.54) ALDH1A1CTSBTDP1MAPK1L3MBTL1
SCHEMBL19105358 0.88 CTSB (0.61) ALDH1A1CTSBTDP1MAPK1L3MBTL1
SCHEMBL8554949 0.88 ALDH1A1 (0.53) ALDH1A1CTSBTDP1MAPK1L3MBTL1
SCHEMBL27505465 0.86 CTSB (0.53) ALDH1A1CTSBTDP1MAPK1L3MBTL1
SCHEMBL998609 0.85 CTSB (0.58) ALDH1A1CTSBTDP1MAPK1L3MBTL1
SCHEMBL2068112 0.85 CTSB (0.58) ALDH1A1CTSBTDP1MAPK1L3MBTL1
SCHEMBL998611 0.85 CTSB (0.58) ALDH1A1CTSBTDP1MAPK1L3MBTL1
SCHEMBL19105400 0.81 ALDH1A1 (0.56) ALDH1A1CTSBTDP1MAPK1L3MBTL1
SCHEMBL16368841 0.79 CTSB (0.53) ALDH1A1CTSBTDP1MAPK1L3MBTL1
SCHEMBL17085306 0.79 CTSB (0.53) ALDH1A1CTSBTDP1MAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0824523-A1 NITRIC OXIDE SYNTHASE INHIBITORS DERIVED FROM CYCLIC AMIDINES G.D. Searle & Co. (US) 1998-02-25 EP disclosed
WO-1996035677-A1 NITRIC OXIDE SYNTHASE INHIBITORS DERIVED FROM CYCLIC AMIDINES G.D. SEARLE & CO. (US) 1996-11-14 WO disclosed